Serum fibroblast growth factor 19 and endogenous islet beta cell function in type 2 diabetic patients

Decrease of FGF19 contributes to the increase of fasting glucose in human in an insulin-independent manner

(2019) J. Zhang et al.   JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION

FGF19 subfamily members: FGF19 and FGF21

(2019) Katarzyna Dolegowska et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

Fibroblast growth factors in control of lipid metabolism

(2019) Dicky Struik et al.   CURRENT OPINION IN LIPIDOLOGY

Enhanced Microbial Bile Acid Deconjugation and Impaired Ileal Uptake in Pregnancy Repress Intestinal Regulation of Bile Acid Synthesis

(2019) Caroline Ovadia et al.   HEPATOLOGY

Blocking Glucagon Like Peptide-1 Receptors in the Exocrine Pancreas Improves Specificity for Beta Cells in a Mouse Model of Type 1 Diabetes

(2019) Eshita Khera et al.   JOURNAL OF NUCLEAR MEDICINE

Plasma FGF-19 Levels are Increased in Patients with Post-Bariatric Hypoglycemia

(2019) Christopher M. Mulla et al.   OBESITY SURGERY

Longitudinal examination of pancreatic β‐cell function in Japanese subjects

(2019) Rumi Fujikawa et al.   Journal of Diabetes Investigation

FGF Family: From Drug Development to Clinical Application

(2018) Qi Hui et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Increased Bile Acids and FGF19 After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass Correlate with Improvement in Type 2 Diabetes in a Randomized Trial

(2018) Reza Nemati et al.   OBESITY SURGERY

A systematic dissection of sequence elements determining β-Klotho and FGF interaction and signaling

(2018) Sally Yu Shi et al.   Scientific Reports

Differential receptor selectivity of the FGF15/FGF19 orthologues determines distinct metabolic activities in db/db mice

(2018) Ann Maria K. Hansen et al.   BIOCHEMICAL JOURNAL

Fibroblast Growth Factor 15/19 – From Basic Functions to Therapeutic Perspectives

(2018) Emmanuel Somm et al.   ENDOCRINE REVIEWS

Quantitative liver proteomics identifies FGF19 targets that couple metabolism and proliferation

(2017) Vittoria Massafra et al.   PLoS One

The relationship between bile acid concentration, glucagon-like-peptide 1, fibroblast growth factor 15 and bile acid receptors in rats during progression of glucose intolerance

(2017) Xinfeng Yan et al.   BMC Endocrine Disorders

Postprandial Plasma Concentrations of Individual Bile Acids and FGF-19 in Patients With Type 2 Diabetes

(2016) David P. Sonne et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Serum Amylase Levels in Relation to Islet β Cell Function in Patients with Early Type 2 Diabetes

(2016) Lei Zhuang et al.   PLoS One

FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but Not After Medical Management in Patients with Type 2 Diabetes

(2015) Saachi Sachdev et al.   OBESITY SURGERY

Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction

(2015) Changtao Jiang et al.   Nature Communications

Serum Fibroblast Growth Factor 19 Levels Are Decreased in Chinese Subjects With Impaired Fasting Glucose and Inversely Associated With Fasting Plasma Glucose Levels

(2013) Qichen Fang et al.   DIABETES CARE

Farnesoid X Receptor Deficiency Improves Glucose Homeostasis in Mouse Models of Obesity

(2011) J. Prawitt et al.   DIABETES

FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis

(2011) S. Kir et al.   SCIENCE

Evaluation of proposed oral disposition index measures in relation to the actual disposition index

(2009) R. Retnakaran et al.   DIABETIC MEDICINE

Hyperbolic Relationship Between Insulin Secretion and Sensitivity on Oral Glucose Tolerance Test

(2008) Ravi Retnakaran et al.   Obesity